S. Gail Eckhardt
Impact in
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 31
- Cancer Treatment and Pharmacology 11
- Colorectal Cancer Treatments and Studies 9
- Neutropenia and Cancer Infections 9
- Lung Cancer Research Studies 7
-
- Cancer, Hypoxia, and Metabolism 7
- Co-authors
- Natalie J. SerkovaJennifer L. SpratlinDaniel D. Von HoffEric K. RowinskyGeoffrey R. WeissJohn R. EckardtLisa A. HammondDavid Rinaldi
- Journals
- Journal of Clinical Oncology (19 papers)Clinical Cancer Research (3 papers)Molecular Cancer Therapeutics (2 papers)European Journal of Cancer (2 papers)Annals of Oncology (2 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
S. Gail Eckhardt
52 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Oncology 1.2k
- Cancer Research 620
- Molecular Biology 1.8k
- Genetics 173
- Hepatology 115
Countries citing papers authored by S. Gail Eckhardt
This map shows the geographic impact of S. Gail Eckhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Gail Eckhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Gail Eckhardt more than expected).
Fields of papers citing papers by S. Gail Eckhardt
This network shows the impact of papers produced by S. Gail Eckhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Gail Eckhardt. The network helps show where S. Gail Eckhardt may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Gail Eckhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2018 | 26 | |
| 4 | 2016 | 2 | |
| 5 | 2016 | 4 | |
| 6 | 2010 | 373 | |
| 7 | 2008 | 23 | |
| 8 | A phase I study of R1507, a human monoclonal antibody IGF-1R (insulin-like growth factor receptor) antagonist given weekly in patients with advanced solid tumors | 2007 | 19 |
| 9 | 2007 | 30 | |
| 10 | 2002 | 37 | |
| 11 | A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies. | 2002 | 112 |
| 12 | A phase I and pharmacokinetic study of ecteinascidin-743 on a daily x 5 schedule in patients with solid malignancies. | 2002 | 75 |
| 13 | 2001 | 32 | |
| 14 | 2000 | 37 | |
| 15 | 1999 | 16 | |
| 16 | 1999 | 69 | |
| 17 | Irinotecan: a review of the initial phase I trials. | 1998 | 7 |
| 18 | 1998 | 24 | |
| 19 | 1996 | 305 | |
| 20 | 1992 | 3 |
About S. Gail Eckhardt
S. Gail Eckhardt is a scholar working on Oncology, Cancer Research, Hepatology, Molecular Biology and Conservation, having authored 54 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (13 papers), Cancer Treatment and Pharmacology (11 papers), Colorectal Cancer Treatments and Studies (9 papers), Neutropenia and Cancer Infections (9 papers), Cancer, Hypoxia, and Metabolism (7 papers), Lung Cancer Research Studies (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (620 citations), Molecular Biology (1.8k citations), Genetics (173 citations) and Hepatology (115 citations). S. Gail Eckhardt has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Natalie J. Serkova, Jennifer L. Spratlin, Daniel D. Von Hoff, Eric K. Rowinsky, Geoffrey R. Weiss, John R. Eckardt, Lisa A. Hammond, David Rinaldi, Roy S. Herbst and John G. Kuhn. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Molecular Cancer Therapeutics, European Journal of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.